We discover, design, and characterize
the advanced materials humanity needs.
At UC San Diego, we leverage our cross-disciplinary expertise to discover, design, and characterize advanced materials needed to address global societal challenges. Our materials work is relevant for developing zero- and low-carbon energy and transportation systems; cost-effective healthcare advances; solutions for natural-resource sustainability; and next-generation information technologies.
This work is grounded in our ability to control materials at the level of atoms and electrons.
Equally important, we are world-leaders in characterizing the structure and function of materials at the nanoscale level using a suite of cutting-edge analytical and theoretical tools, many of which we have developed here at UC San Diego.
Nanoengineers receive $4.3M from NIH to continue studies using plant viruses to treat cancer
October 17, 2022
Researchers led by Nicole Steinmetz, professor of nanoengineering at the University of California San Diego, have received $4.3 million in grants from the National Institutes of Health (NIH) to advance their research using plant viruses to develop cancer immunotherapies. Full Story
Setting the stage for solid-state battery success
August 2, 2022
Battery researchers and other engineers from University of California San Diego, with collaboration from the LG Energy Solution, have published a forward-looking perspective article in the journal Joule. In the article, the researchers outline three categories of engineering challenges that must be solved in order to transition all-solid-state batteries from the laboratory toward large-scale industrial manufacturing. These three challenges are that of precursors, processing and pressure. Full Story
Plant virus plus immune cell-activating antibody clear colon cancer in mice, prevent recurrence
June 21, 2022
A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system’s “natural killer” cells, shows a study by researchers at the University of California San Diego. In mouse models of colon cancer, the combination therapy eliminated all tumors and prevented their recurrence, which in turn resulted in 100% survival. The therapy also increased survival in mouse models of melanoma. Full Story